Clinical Trials
7 trialsNCT02465060 2026-05-26
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT02993523 2026-05-15
Viale-a
AbbVie
Phase 3 Completed
NCT04067336 2026-05-13
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Phase 1/2 Active not recruiting
NCT02970318 2026-05-11
A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL
Acerta Pharma BV
Phase 3 Active not recruiting
NCT03399799 2026-05-08
MonumenTAL-1
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT04634552 2026-05-08
MonumenTAL-1
Janssen Research & Development, LLC
Phase 2 Recruiting
NCT03625037 2026-05-05
EPCOREâ„¢ NHL-1
Genmab
Phase 1/2 Active not recruiting